USTR holds talks with Pfizer, Astrazeneca over increased vaccine production, IP rights waiver
The Hindu
The United States so far has remained non-committal on the WTO move of India and South Africa over this.
United States Trade Representative Katherine Tai has held a virtual meeting with AstraZeneca and Pfizer leadership to discuss increasing vaccine production and a proposed waiver to certain provisions of the World Trade Organisation’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) for the COVID-19 pandemic. The United States so far has remained non-committal on the WTO move of India and South Africa over this. The White House on Monday told reporters that no decision has been made yet, even as top American lawmakers urged the Biden Administration to support the move at WTO to provide TRIPS waiver to COVID-19 vaccines.More Related News
One dies, eight hospitalised after inhaling HCL fumes at pharma company in Andhra Pradesh’s Anakapalli district. About 400 litres of HCL leaked from the reactor-cum-receiver tank at Unit-III of the company, which affected nine workers, says Collector. While the condition of six of them is stable, two are on ventilator support. Chief Minister Chandrababu Naidu directs authorities to provide advanced treatment to the victims. Home Minister Anitha expresses anger over repeated such incidents.